Skip to content
JournalsWorldThe Global Research Discovery Platform
Login Sign Up
SCHOLARLY PUBLICATION ✓ Open Access

Use of complementary and alternative medicine in cancer patients: a European survey

Alex Molassiotis, Paz Fernández‐Ortega, Dorit Pud, Gülten Özden, Jane Anne Scott, Vassiliki Panteli, Anita Margulies, Maria Browall, Miriam Magri, Šárka Selvekerová, Elin Madsen, Ljiljana Milovics, Ingrid Bruyns, Guðbjörg Guðmundsdóttir, S. Hummerston, Aftab M. Ahmad, Nurgün Platin, Nora Kearney, Elisabeth I. Patiraki

📖 Annals of Oncology → 📅 2005-02-03 🔗 DOI: 10.1093/annonc/mdi110
View Journal Profile → ⬇ Download PDF View Official Paper ↗

📄 Abstract

The abstract has not yet been added. Use the official source link for the complete publication record.

🔬 Related Research Papers

Annals of Oncology

A decade of clinical development of PARP inhibitors in perspective

J. Mateo, Christopher J. Lord et al. 2019-06-17 · Read paper → Annals of Oncology

Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer

David W. Miles, Joseph Gligorov et al. 2021-07-01 · Read paper → Annals of Oncology

Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

Paolo Giovanni Casali, Nuno Abecassis et al. 2018-03-28 · Read paper → Annals of Oncology

European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition—Summary Document

Marc Arbyn, Ahti Anttila et al. 2010-02-22 · Read paper → Annals of Oncology

Management of febrile neutropaenia: ESMO Clinical Practice Guidelines

Jean A. Klastersky, Julien de Naurois et al. 2016-09-01 · Read paper → Annals of Oncology

Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors

David Westover, Jon Zugazagoitia et al. 2018-01-01 · Read paper → Annals of Oncology

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial

Yoon‐Koo Kang, Won Ki Kang et al. 2009-01-19 · Read paper → Annals of Oncology

Regulation of PD-L1: a novel role of pro-survival signalling in cancer

Jiezhong Chen, Chen Chen Jiang et al. 2015-12-17 · Read paper → Annals of Oncology

Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study

Carsten Bokemeyer, Igor Bondarenko et al. 2011-01-12 · Read paper → Annals of Oncology

High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Roger Stupp, M. Brada et al. 2014-04-30 · Read paper → Annals of Oncology

OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician’s choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer

Mark E. Robson, Nadine Tung et al. 2019-01-16 · Read paper → Annals of Oncology

Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology

Elaine Johanna Limkin, Roger Sun et al. 2017-02-07 · Read paper →